Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens

The increasing prevalence of drug-resistant bacteria has prompted the search for alternative approaches to address bacterial infections. Lanthipeptides, which are small molecule peptides, are biosynthesized and post-translationally modified by ribosomes in gram-positive bacteria. These compounds pos...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenya Zhao, Yang Zhang, Xue Yang, Jianuo He, Yana Wang, Feiyan Zhang, Liping Zhang, Hongwei Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13102818.2024.2402447
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850163737982402560
author Wenya Zhao
Yang Zhang
Xue Yang
Jianuo He
Yana Wang
Feiyan Zhang
Liping Zhang
Hongwei Liu
author_facet Wenya Zhao
Yang Zhang
Xue Yang
Jianuo He
Yana Wang
Feiyan Zhang
Liping Zhang
Hongwei Liu
author_sort Wenya Zhao
collection DOAJ
description The increasing prevalence of drug-resistant bacteria has prompted the search for alternative approaches to address bacterial infections. Lanthipeptides, which are small molecule peptides, are biosynthesized and post-translationally modified by ribosomes in gram-positive bacteria. These compounds possess distinctive target recognition properties, making them highly potential candidates for combating antimicrobial resistance. Consequently, they hold promising potential as innovative substitutes for traditional antibiotics. We conducted a comprehensive analysis of 65 publicly available Bacillus amyloliquefaciens genomes’ data to explore the potential for lanthipeptide synthesis in this species. We annotated 21 putative precursor peptide genes for these novel lanthipeptides. Through heterologous expression experiments, we successfully obtained a novel lanthipeptide named amyA3. We accomplished a novel co-transformation strategy by introducing the synthetic enzyme obtained from B. amyloliquefaciens WS-8 into the E. coli BL21 (DE3) strain along with the heterologous precursor peptide amyA3. Through mass spectrometry analysis, we confirmed the successful modification of amyA3 by the synthetic enzyme derived from B. amyloliquefaciens WS-8, which represents a significant breakthrough in this research field. The identification and characterization of the lanthipeptide amyA3 along with the elucidation of its biosynthetic pathway provide novel perspectives into the discovery of naturally derived products and the intricate processes of translation and post-translational modifications.
format Article
id doaj-art-cb8a9d4c27f34c34a432533140f7fb2b
institution OA Journals
issn 1310-2818
1314-3530
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Biotechnology & Biotechnological Equipment
spelling doaj-art-cb8a9d4c27f34c34a432533140f7fb2b2025-08-20T02:22:10ZengTaylor & Francis GroupBiotechnology & Biotechnological Equipment1310-28181314-35302024-12-0138110.1080/13102818.2024.2402447Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciensWenya Zhao0Yang Zhang1Xue Yang2Jianuo He3Yana Wang4Feiyan Zhang5Liping Zhang6Hongwei Liu7Institute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaInstitute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaInstitute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaInstitute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaInstitute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaInstitute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaInstitute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaInstitute of Biology, Hebei Academy of Science, Shijiazhuang, P.R. ChinaThe increasing prevalence of drug-resistant bacteria has prompted the search for alternative approaches to address bacterial infections. Lanthipeptides, which are small molecule peptides, are biosynthesized and post-translationally modified by ribosomes in gram-positive bacteria. These compounds possess distinctive target recognition properties, making them highly potential candidates for combating antimicrobial resistance. Consequently, they hold promising potential as innovative substitutes for traditional antibiotics. We conducted a comprehensive analysis of 65 publicly available Bacillus amyloliquefaciens genomes’ data to explore the potential for lanthipeptide synthesis in this species. We annotated 21 putative precursor peptide genes for these novel lanthipeptides. Through heterologous expression experiments, we successfully obtained a novel lanthipeptide named amyA3. We accomplished a novel co-transformation strategy by introducing the synthetic enzyme obtained from B. amyloliquefaciens WS-8 into the E. coli BL21 (DE3) strain along with the heterologous precursor peptide amyA3. Through mass spectrometry analysis, we confirmed the successful modification of amyA3 by the synthetic enzyme derived from B. amyloliquefaciens WS-8, which represents a significant breakthrough in this research field. The identification and characterization of the lanthipeptide amyA3 along with the elucidation of its biosynthetic pathway provide novel perspectives into the discovery of naturally derived products and the intricate processes of translation and post-translational modifications.https://www.tandfonline.com/doi/10.1080/13102818.2024.2402447LanthipeptideBacillus amyloliquefaciensheterologous expressiongenome mininggene cluster
spellingShingle Wenya Zhao
Yang Zhang
Xue Yang
Jianuo He
Yana Wang
Feiyan Zhang
Liping Zhang
Hongwei Liu
Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens
Biotechnology & Biotechnological Equipment
Lanthipeptide
Bacillus amyloliquefaciens
heterologous expression
genome mining
gene cluster
title Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens
title_full Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens
title_fullStr Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens
title_full_unstemmed Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens
title_short Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens
title_sort mining public genomic databases for novel lanthipeptides a case study on bacillus amyloliquefaciens
topic Lanthipeptide
Bacillus amyloliquefaciens
heterologous expression
genome mining
gene cluster
url https://www.tandfonline.com/doi/10.1080/13102818.2024.2402447
work_keys_str_mv AT wenyazhao miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens
AT yangzhang miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens
AT xueyang miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens
AT jianuohe miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens
AT yanawang miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens
AT feiyanzhang miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens
AT lipingzhang miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens
AT hongweiliu miningpublicgenomicdatabasesfornovellanthipeptidesacasestudyonbacillusamyloliquefaciens